The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
The Vast and Varied Global Burden of Norovirus: Prospects for Prevention and Control
Open accessAbstract
Globally, norovirus is associated with approximately one-fifth of all diarrhea cases, with similar prevalence in both children and adults, and is estimated to cause over 200,000 deaths annually in developing countries. Norovirus is an important pathogen in a number of high-priority domains: it is the most common cause of diarrheal episodes globally, the principal cause of foodborne disease outbreaks in the United States, a key health care-acquired infection, a common cause of travel-associated diarrhea, and a bane for deployed military troops. Partly as a result of this ubiquity and burden across a range of different populations, identifying target groups and strategies for intervention has been challenging. And, on top of the breadth of this public health problem, there remain important gaps in scientific knowledge regarding norovirus, especially with respect to disease in low-income settings. Many pathogens can cause acute gastroenteritis. Historically, rotavirus was the most common cause of severe disease in young children globally. Now, vaccines are available for rotavirus and are universally recommended by the World Health Organization. In countries with effective rotavirus vaccination programs, disease due to that pathogen has decreased markedly, but norovirus persists and is now the most common cause of pediatric gastroenteritis requiring medical attention. However, the data supporting the precise role of norovirus in low- and middle-income settings are sparse. With vaccines in the pipeline, addressing these and other important knowledge gaps is increasingly pressing. We assembled an expert group to assess the evidence for the global burden of norovirus and to consider the prospects for norovirus vaccine development. The group assessed the evidence in the areas of burden of disease, epidemiology, diagnostics, disease attribution, acquired immunity, and innate susceptibility, and the group considered how to bring norovirus vaccines from their current state of development to a viable product that will benefit global health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Kotloff, K. L., Nataro, J. P., Blackwelder, W. C., Nasrin, D., Farag, T. H., Panchalingam, S., Wu, Y., Sow, S. O., Sur, D., Breiman, R. F., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60844-2 · Cited by 3,560 · cited 1×
“The recent Global Enterics Multi-Center Study (GEMS) is the largest systematic assessment for understanding the etiology of childhood diarrhea in developing countries [31].”
BackgroundLiu, L., Oza, S., Hogan, D., Perin, J., Rudan, I., Lawn, J. E., Cousens, S., Mathers, C., & Black, R. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61698-6 · Cited by 3,167 · cited 1×
“Over the same period, improvements specifically for children under 5 years of age have been most impressive, with rates of decline in diarrheal deaths at around 5% per year, in absolute numbers, to an estimate of 578,000 deaths in 2013 [2].”
BackgroundKirk, M. D., Pires, S. M., Black, R. E., Caipo, M., Crump, J. A., Devleesschauwer, B., Döpfer, D., Fazil, A., Fischer-Walker, C. L., Hald, T., et al. (2015) · PLoS Medicine · doi:10.1371/journal.pmed.1001921 · Cited by 1,625 · cited 2×
“Norovirus was estimated to cause 684 million (95% Uncertainty Interval 491–1,112 million) episodes of diarrheal disease and 212,000 deaths, annually, for all ages and from all modes of transmission [5,10].”
BackgroundGlobal prevalence of norovirus in cases of gastroenteritis: a systematic review and meta-analysis
Ahmed, S. M., Hall, A. J., Robinson, A. E., Verhoef, L., Premkumar, P., Parashar, U. D., Koopmans, M., & Lopman, B. A. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70767-4 · Cited by 1,122
Self-citationPlatts-Mills, J. A., Babji, S., Bodhidatta, L., Gratz, J., Haque, R., Havt, A., McCormick, B. J., McGrath, M., Olortegui, M. P., Samie, A., et al. (2015) · The Lancet Global Health · doi:10.1016/s2214-109x(15)00151-5 · Cited by 894
Enteric bacteria promote human and mouse norovirus infection of B cells
Jones, M. K., Watanabe, M., Zhu, S., Graves, C. L., Keyes, L. R., Grau, K. R., Gonzalez-Hernandez, M. B., Iovine, N. M., Wobus, C. E., Vinjé, J., et al. (2014) · Science · doi:10.1126/science.1257147 · Cited by 769
Advances in Laboratory Methods for Detection and Typing of Norovirus
Vinjé, J. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.01535-14 · Cited by 750
Norovirus and Medically Attended Gastroenteritis in U.S. Children
Payne, D. C., Vinjé, J., Szilagyi, P. G., Edwards, K. M., Staat, M. A., Weinberg, G. A., Hall, C. B., Chappell, J., Bernstein, D. I., Curns, A. T., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmsa1206589 · Cited by 610
Self-citationNorovirus Disease in the United States
Hall, A. J., Lopman, B. A., Payne, D. C., Patel, M. M., Gastañaduy, P. A., Vinjé, J., & Parashar, U. D. (2013) · Emerging Infectious Diseases · doi:10.3201/eid1908.130465 · Cited by 585
Self-citationGlobal Economic Burden of Norovirus Gastroenteritis
Bartsch, S. M., Lopman, B. A., Ozawa, S., Hall, A. J., & Lee, B. Y. (2016) · PLOS ONE · doi:10.1371/journal.pone.0151219 · Cited by 567
Self-citationTam, C. C., Rodrigues, L. C., Viviani, L., Dodds, J. P., Evans, M. R., Hunter, P. R., Gray, J. J., Letley, L. H., Rait, G., Tompkins, D. S., et al. (2012) · Gut · doi:10.1136/gut.2011.238386 · Cited by 564
Norovirus Vaccine against Experimental Human Norwalk Virus Illness
Atmar, R. L., Bernstein, D. I., Harro, C. D., Al-Ibrahim, M. S., Chen, W. H., Ferreira, J., Estes, M. K., Graham, D. Y., Opekun, A. R., Richardson, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1101245 · Cited by 490
Clinical Immunity in Acute Gastroenteritis Caused by Norwalk Agent
Parrino, T. A., Schreiber, D. S., Trier, J. S., Kapikian, A. Z., & Blacklow, N. R. (1977) · New England Journal of Medicine · doi:10.1056/nejm197707142970204 · Cited by 478
Pires, S. M., Fischer-Walker, C. L., Lanata, C. F., Devleesschauwer, B., Hall, A. J., Kirk, M. D., Duarte, A. S. R., Black, R. E., & Angulo, F. J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0142927 · Cited by 445
Commensal microbes and interferon-λ determine persistence of enteric murine norovirus infection
Baldridge, M. T., Nice, T. J., McCune, B. T., Yokoyama, C. C., Kambal, A., Wheadon, M., Diamond, M. S., Ivanova, Y., Artyomov, M., & Virgin, H. W. (2015) · Science · doi:10.1126/science.1258025 · Cited by 412
Epochal Evolution of GGII.4 Norovirus Capsid Proteins from 1995 to 2006
Siebenga, J. J., Vennema, H., Renckens, B., de Bruin, E., van der Veer, B., Siezen, R. J., & Koopmans, M. (2007) · Journal of Virology · doi:10.1128/jvi.00674-07 · Cited by 389
Wyatt, R. G., Dolin, R., Blacklow, N. R., DuPont, H. L., Buscho, R. F., Thornhill, T. S., Kapikian, A. Z., & Chanock, R. M. (1974) · Journal of Infectious Diseases · doi:10.1093/infdis/129.6.709 · Cited by 360
Bernstein, D. I., Atmar, R. L., Lyon, G. M., Treanor, J. J., Chen, W. H., Jiang, X., Vinje, J., Gregoricus, N., Frenck, R. W., Moe, C. L., et al. (2015) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu497 · Cited by 276
Virus-helminth coinfection reveals a microbiota-independent mechanism of immunomodulation
Osborne, L. C., Monticelli, L. A., Nice, T. J., Sutherland, T. E., Siracusa, M. C., Hepworth, M. R., Tomov, V. T., Kobuley, D., Tran, S. V., Bittinger, K., et al. (2014) · Science · doi:10.1126/science.1256942 · Cited by 271
Desai, R., Hembree, C. D., Handel, A., Matthews, J. E., Dickey, B. W., McDonald, S., Hall, A. J., Parashar, U. D., Leon, J. S., & Lopman, B. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis372 · Cited by 184
Self-citationBucardo, F., Reyes, Y., Svensson, L., & Nordgren, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098201 · Cited by 176
Phillips, G., Tam, C. C., Conti, S., Rodrigues, L. C., Brown, D., Iturriza‐Gómara, M., Gray, J. J., & Lopman, B. A. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq021 · Cited by 147
Self-citationRisk Factors for Norovirus, Sapporo-like Virus, and Group A Rotavirus Gastroenteritis
de Wit, M. A. S., Koopmans, M., & van Duynhoven, Y. T. (2003) · Emerging infectious diseases · doi:10.3201/eid0912.020076 · Cited by 135
Serological Correlates of Protection against a GII.4 Norovirus
Atmar, R. L., Bernstein, D. I., Lyon, G. M., Treanor, J. J., Al-Ibrahim, M. S., Graham, D. Y., Vinjé, J., Jiang, X., Gregoricus, N., Frenck, R. W., et al. (2015) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00196-15 · Cited by 132
Rotavirus vaccines: Current status and future considerations
Yen, C., Tate, J. E., Hyde, T. B., Cortese, M. M., Lopman, B. A., Jiang, B., Glass, R. I., & Parashar, U. D. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.28857 · Cited by 108
Self-citationEpidemiologic Implications of Asymptomatic Reinfection: A Mathematical Modeling Study of Norovirus
Lopman, B. A., Simmons, K., Gambhir, M., Vinjé, J., & Parashar, U. D. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kwt287 · Cited by 105
Self-citationGrytdal, S., DeBess, E. E., Lee, L. E., Blythe, D., Ryan, P., Biggs, C., Cameron, M. L., Schmidt, M. A., Parashar, U. D., & Hall, A. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148395 · Cited by 83
Self-citationCorrelates of Protection against Norovirus Infection and Disease—Where Are We Now, Where Do We Go?
Ramani, S., Estes, M. K., & Atmar, R. L. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005334 · Cited by 72
The estimated disease burden of norovirus in The Netherlands
Verhoef, L., Koopmans, M., van Pelt, W., Duizer, E., Haagsma, J. A., Werber, D., van Asten, L., & Havelaar, A. H. (2012) · Epidemiology and Infection · doi:10.1017/s0950268812000799 · Cited by 61
Shioda, K., Cosmas, L., Audi, A. O., Gregoricus, N., Vinjé, J., Parashar, U. D., Montgomery, J. M., Feikin, D. R., Breiman, R. F., & Hall, A. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0145943 · Cited by 43
Self-citationMethods of Analysis of Enteropathogen Infection in the MAL-ED Cohort Study
Platts-Mills, J. A., McCormick, B., Kosek, M. N., Pan, W., Checkley, W., & Houpt, E. R. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu408 · Cited by 34
Allen, D. J., Trainor, E., Callaghan, A. W., O’Brien, S. J., Cunliffe, N. A., & Iturriza‐Gómara, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146972 · Cited by 26
Cited by
The Burden and Etiology of Diarrheal Illness in Developing Countries.
Kotloff, K. L. (2017) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2017.03.006 · Cited by 270
Cannon, J. L., Barclay, L., Collins, N. R., Wikswo, M. E., Castro, C. J., Magaña, L. C., Gregoricus, N., Marine, R. L., Chhabra, P., & Vinjé, J. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00455-17 · Cited by 286
Common and potential emerging foodborne viruses: a comprehensive review
Olaimat, A., Taybeh, A., Al-Nabulsi, A., Al-Holy, M., Hatmal, M., Alzyoud, J., Aolymat, I., Abughoush, M., Shahbaz, H., Alzyoud, A., et al. (2024) · Life · doi:10.3390/life14020190 · Cited by 52
“[31].”
Metadata
- Authors
- Lopman, B. A., Steele, D., Kirkwood, C. D., & Parashar, U. D.
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-04-26
- Volume
- 13
- Issue
- 4
- Pages
- e1001999
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2343412274
- Cited by
- 457
- References
- 34
- FWCI
- 35.29
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.